Phase 2 Dyslipidemia Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 2
Impact of Obicetrapib and Obicetrapib Plus Repatha on Lp(a) Levels
Dyslipidemias
NewAmsterdam Pharma69 enrolled1 locationNCT06496243
Recruiting
Phase 2
Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia
Dyslipidemias
Ribocure Pharmaceuticals AB120 enrolled4 locationsNCT06797401
Recruiting
Phase 2
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Cardiovascular DiseasesHIV InfectionsAtherosclerosis+1 more
Priscilla Hsue, MD121 enrolled3 locationsNCT05488431
Recruiting
Phase 1Phase 2
Integrated Traditional Chinese Medicine Day Care Program for Metabolic Syndrome
Diabetes MellitusObesityMetabolic Syndrome+1 more
Chang Gung Memorial Hospital200 enrolled1 locationNCT06703788
Recruiting
Phase 2Phase 3
Effects of Phytoestrogen From Pueraria Mirifica in Improvement of Serum Lipid Parameters in Postmenopausal Women
DyslipidemiasPostmenopausal SymptomsHypercholesterolemia+3 more
Dhurakij Pundit University10 enrolled1 locationNCT06220266